Medical Tubing Market Outlook:
Medical Tubing Market size was valued at USD 10.1 billion in 2024 and is projected to reach USD 21.7 billion by the end of 2037, rising at a CAGR of 8.1% during the forecast period, 2025-2037. In 2025, the industry size of medical tubing is estimated at USD 10.9 billion.
The global patient pool for medical tubing continues to rise with the increase in chronic illness rates. As per the Centers for Medicare & Medicaid Services, nearly 60.3 million Medicare beneficiaries use healthcare services in the U.S. that mostly involve medical tubing such as dialysis, catheterization, IV therapies, and respiratory support. Further, the CDC report shows a 15.3% rise in chronic kidney disease among U.S. adults, requiring dialysis tubing systems. These demands are paralleled by increased usage of diabetes management, oncology care, and cardiovascular interventions, fueling the advanced tubing components in home care setups and hospitals.
On the supply chain side, the market spans polymer extrusion and molding operations, extractions, and clean room assembly. As per the U.S. International Trade Commission report, the U.S. imports plastic medical device components worth USD 2.9 billion in 2023. Further, the raw polymers are imported from Germany, Japan, and China for manufacturing extruded medical-grade silicone and fluoropolymer tubing. Changes in tariffs or trade disruptions from Asia-Pacific suppliers might have a big impact on the tubing supply chain. According to the BLS report, the producer price index for surgical and medical instruments grew 6.5% in 2024, while the consumer price index for medical care rose to 4.8% costing pressure for B2B procurement strategies for OEMs and distributors.
Medical Tubing Market - Growth Drivers and Challenges
Growth Drivers
- Rising government healthcare spending via Medicare and Medicaid: The government programs nowadays are actively investing in medical devices, including tubing systems for both home-based treatments and in hospitals. As per Medicare, spending on catheter-based care and infusion therapies increased to USD 2.6 billion in 2023, with the catheter expenses alone growing 11.3% every year, impacting the broader applications in chronic disease management. A greater variety of items connected to tubing are now included by reimbursement codes under the Healthcare Common Procedure Coding System (HCPCS).
- Healthcare quality improvement initiatives: A 2022 AHRQ study showed that widespread use of sterile, disposable medical tubing in U.S. acute care facilities decreased CLABSIs by 28.4%, saving an estimated USD 472.6 million on national hospitalization expenditures during two years. Such evidence supports increased procurement of good-quality tubing systems in quality improvement initiatives. This minimization in cost has led to a 19.2% decrease in ICU stay period, focusing on the clinical efficiency of advanced tubing systems.
Historical Patient Growth & Its Impact on Market Dynamics
Historical Patient Growth (2010-2020) in Key Markets
|
Country |
Patients (2010) |
Patients (2020) |
% Growth (2010–2020) |
|
U.S. |
21.9 million |
30.2 million |
+38.9% |
|
Germany |
6.1million |
7.9 million |
+28.1% |
|
France |
4.5 million |
5.8 million |
+31.2% |
|
Spain |
3.5 million |
4.7 million |
+35.8% |
|
Australia |
2.4 million |
3.0 million |
+42.4% |
|
Japan |
9.9 million |
12.8 million |
+30.8% |
|
India |
11.7 million |
18.9 million |
+63.2% |
|
China |
25.9 million |
42.6 million |
+64.9% |
|
Country |
Expansion Model |
Revenue Growth (%) |
Key Approach |
|
India |
Public-private partnerships with NHM hospitals |
+12.4% |
State-level device procurement model |
|
U.S. |
Medicare-driven device reimbursements |
+9.7% |
Local tubing assembly & CMS-backed expansion |
|
Germany |
Sustainable material compliance in hospital procurement |
+8.1% |
ESG-focused manufacturing and supply agreements |
|
China |
Regional distributor bundling with provincial hospitals |
+14.5% |
Volume-based local tenders and tax incentives |
|
France |
Hospital-university partnerships for R&D tubing products |
+8.7% |
Academic-medical innovation consortiums |
Challenges
- Government-imposed pricing caps and budgetary constraints: In Europe, the national healthcare systems impose a robust price ceiling to contain expenditures. For example, the national health procurement authority in France restricted single-use medical device price increases to less than 2.5% YoY, which constrained supplier profitability. On the other hand, Germany’s G-DRG hospital payment system enforces bundled payment models, manufacturing high-quality tubing options with less financially attractive and funded by insurers.
Medical Tubing Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
8.1% |
|
Base Year Market Size (2024) |
USD 10.1 billion |
|
Forecast Year Market Size (2037) |
USD 21.7 billion |
|
Regional Scope |
|
Medical Tubing Market Segmentation:
End user Segment Analysis
In the end user segment, hospitals and clinics are dominating the market and lead the market share with 35.2% by 2037. Hospitals continue to be the main consumers of medical tubing, especially for post-operative and surgical care. There has been a steady rise in procedural volumes in the acute care environment, which requires high tubing volumes for oxygenation, drainage, catheterization, and fluid infusion, as reported by AHRQ.gov (Agency for Healthcare Research and Quality). Growing hospital bed capacity and government reimbursement for inpatient devices are also forces driving tubing consumption.
Application Segment Analysis
Under the application segment, bulk disposable tubing holds the maximum share in the segment and is expected to have 32.8% of revenue share by 2037. This rise is due to the increase in demand for single-use medical devices, which avoid infection risks and minimize sterilization costs. The WHO strongly recommends disposable tubes in hospitals for blood bags, respiratory circuits, and IVs for infection control in the ICU. Further, according to the CDC and WHO, disposable tubing systems are widely used because nosocomial infections in intensive care units continue to be a global problem. Additionally, the rise in home infusion therapies and outpatients, especially during post-COVID, made the demand strong.
Our in-depth analysis of the global market includes the following segments:
|
Segment |
Subgement |
|
Application |
|
|
Material |
|
|
End user |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Medical Tubing Market - Regional Analysis
North America Market Insights
North America is the dominant player in the medical tubing market and is expected to hold the market share of 32.9% by 2037 at a CAGR of 7.4%. The market is mainly driven by the increase in healthcare infrastructure investment, aging population, and access to reimbursement via Medicare and Medicaid. More than 125.6 million people were insured by Medicare and Medicaid combined as of 2024, and demand is still being stimulated by the expansion of reimbursement codes for respiratory tubing and catheterization. The continued growth of the region is expected through localization strategies, national health coverage extensions, and favorable regulatory frameworks. The region will remain dominant due to the strong healthcare funding, active R&D innovation, and high disease burden.
The medical tubing market in the U.S. is positioned to showcase sustained growth driven by strong federal reimbursement reforms, healthcare expansion, and an aging population. As per Medicare, medical tubing-related reimbursements rose by 15.4% in the past five years, reaching USD 800.2 million. Increase in healthcare funding impacts the policy enhancements, allowing coverage of enteral feeding, dialysis, and respiratory tubing kits for elderly patients. Similarly, Medicaid has allocated USD 1.4 billion in 2024 to broaden access by 10.4% via inclusion in chronic illness packages.
Asia Pacific Regional Insights
The APAC is the fastest growing region in the medical tubing market and is projected to have a market share of 25.2% with a CAGR of 8.5% by 2037. The market is driven by rapid healthcare infrastructure expansion, rising chronic disease, increased surgical volumes and public investments in medical devices. The Asia Pacific region is emerging as a global production due to low manufacturing costs, proximity to raw materials and increasing policies. Infection control, sustainability, and import substitution are given top priority in government activities in these nations. APAC market has robust mid- to long-term prospects for manufacturers specializing in extrusion, material science, and sterile packaging as regulatory frameworks develop and local manufacturing picks up steam.
China holds the maximum share in the medical tubing market and is expected to hold the market share of 10.2% by 2037. As per NMPA, China, over the past five years, has increased the medical consumables such as tubing by 15.6%. Further, in 2023, over 1.7 million patients required tubing treatments, which is fueled by chronic disease prevalence and national insurance expansion. The Healthy China 2030 Plan prioritizes the use of tubing in diagnostics, surgeries, and infection control, and it provides tax rebates and raw material subsidies to local providers.
APAC Government Investment & Policy Table (2021–2025)
|
Country |
Policy / Program |
Launch Year |
Budget / Funding (USD) |
|
Australia |
National Medical Products Reform Strategy |
2022 |
USD 320.5 million (device manufacturing grants) |
|
Japan |
Advanced Medical Device R&D Fund (via AMED) |
2021 |
USD 580.7 million allocated by 2024 |
|
India |
Production Linked Incentive (PLI) Scheme for Medical Devices |
2021 |
USD 475.2 million for domestic tubing production |
|
South Korea |
Korean Biomedical Industrial Development Plan |
2023 |
USD 290.8 million for smart manufacturing hubs |
|
Malaysia |
Medical Device Authority (MDA) Device Localisation Program |
2022 |
USD 120.6 million for tubing & component systems |
Europe Regional Insights
The medical tubing market in Europe is projected to hold a market share of 28.6% at a CAGR of 6.9% in 2037. The market in Europe is driven by a rising aging population, public health systems, expanded EU and national level investments in healthcare sectors. Germany and the UK hold the maximum share in the EU region and is largely contributed to chronic illness prevalence and transforming towards infection-resistant due to single-use tubing in ICUs and surgical settings. Further, the market in 2023 has expanded by over 10.3% every year with €500.3 million investment from the EU health fund. Factors such as innovation, cross border R&D and minimal investment in treatment infrastructure make the Europe market to have a stable, and regulatory friendly growth for tubing suppliers.
Germany holds the maximum share in the EU region and is expected to hold the market share of 8.9% by 2037. Various factors drive Germany’s medical tubing market, such as universal insurance coverage, robust public healthcare infrastructure, and DRG-based reimbursement for chronic and catheterization disease management. Germany's emphasis on preventing hospital-acquired infections has resulted in widespread use of tubes with antimicrobial coatings and biocompatible materials, which are now included in public procurement frameworks. As per the BMG report, nearly 70.4% of tertiary hospitals now use tubing replacement and sterilization guidelines. Germany is positioned to have a greater volume of innovation for both the EU and domestic supply.
Key Medical Tubing Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The global market is competitive led with innovation by leading manufacturers in the market. The key players such as Saint-Gobain, Zeus, and Freudenberg Medical invest highly in precision extrusion, multi-lumen tubing and biocompatible polymers to cater chronic disease applications. Some strategies like local manufacturing expansion, Strategic collaborations, and acquisitions, are key to market positioning. For example, Zeus Industrial Products has partnered with leading OEMs to provide high performance for robotic surgery in 2024. Similarly, Raumedic AG and Putnam Plastics extend their extrusion capabilities in North America and Europe focusing to reduce regulatory complexities and lead times.
Top players in this market are:
|
Company Name |
Country |
Industry Focus |
Market Share (%) |
|
Saint-Gobain Performance Plastics |
France |
High-performance silicone, PVC, and fluoropolymer medical tubing for fluid transfer, IV, and diagnostic use. |
7.9% |
|
Zeus Industrial Products |
U.S. |
Specializes in precision-extruded PTFE and fluoropolymer tubing for cardiovascular, neurovascular, and catheter markets. |
7.1% |
|
Nordson Corporation |
U.S. |
Manufactures medical tubing extrusion systems and microbore tubing for minimally invasive surgery and diagnostics. |
6.8% |
|
Freudenberg Medical |
Germany |
Develops multi-lumen silicone tubing and catheter delivery systems for OEMs in Europe and North America. |
6.5% |
|
Raumedic AG |
Germany |
Focuses on thermoplastic and silicone tubing for enteral feeding, respiratory, and IV systems. |
5.8% |
|
Teleflex Medical OEM |
U.S. |
Offers custom-engineered tubing for interventional devices, hemodialysis, and surgical drainage systems. |
xx% |
|
Optinova Group |
Finland |
Produces high-precision fluoropolymer tubing for infusion therapy and cardiovascular applications. |
xx% |
|
Tekni-Plex Medical |
U.S. |
Manufactures multi-layer medical tubing using PVC, TPE, and polyolefins, supporting diagnostics and delivery systems. |
xx% |
|
Putnam Plastics Corporation |
U.S. |
Supplies advanced extrusion tubing used in catheters and delivery systems for minimally invasive surgeries. |
xx% |
|
MDC Engineering (QMD™) |
U.S. |
Specializes in precision medical tubing and catheter components, mainly for OEMs in interventional applications. |
xx% |
|
Lubrizol Life Science Health |
U.S. |
Develops thermoplastic polyurethane tubing for use in surgical and wearable medical devices. |
xx% |
|
A.P. Extrusion Inc. |
U.S. |
Focuses on custom micro-extruded tubing for clinical and diagnostic use in North America. |
xx% |
|
Samyang Biopharm |
South Korea |
Manufactures biocompatible polymer-based tubing and catheters, mainly for hospital-grade IV and infusion systems. |
xx% |
|
Nipro Corporation |
Japan |
Produces disposable tubing for dialysis, transfusion, and IV applications across Asia-Pacific and Latin America. |
xx% |
|
Weigao Group Medical Polymer |
China |
Develops infusion sets and flexible tubing systems for single-use healthcare products. |
xx% |
|
S3 Medical (CATH RX) |
Australia |
Designs and manufactures cardiovascular tubing and delivery systems, especially for catheter-based cardiac therapy. |
xx% |
|
Poly Medicure Ltd. |
India |
India’s leading exporter of IV infusion, dialysis, and blood transfusion tubing systems. |
xx% |
|
Terumo Corporation |
Japan |
Global manufacturer of medical devices with a focus on high-grade tubing for vascular access, perfusion, and infusion. |
xx% |
|
Top Glove Medical Devices |
Malaysia |
Expanding into medical tubing manufacturing, focusing on latex and silicone-based respiratory and IV tubing. |
xx% |
|
Qosina Corp. |
U.S. |
Distributor and OEM supplier of off-the-shelf medical-grade tubing and connectors, mainly serving clinical and R&D markets. |
xx% |
Below are the areas covered for each company in the market:
Recent Developments
- In April 2024, Zeus Industrial Products launched PTFE Heat-Shrink Tubing Series designed specifically for neurovascular catheter assemblies, offering enhanced thermal stability, flexibility, and reduced particulate contamination. The post-launch has contributed 9.3% rise in catheter-related sales.
- In May 2024, Freudenberg Medical launched Helix iMC tubing technology, integrating multi-lumen configurations and embedded sensor capability into a single silicone extrusion. The launch has increased the catheter systems by 6.7% YoY.
- Report ID: 3536
- Published Date: Jul 02, 2025
- Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Medical Tubing Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
